<?xml version="1.0" encoding="UTF-8"?>
<akn:akomaNtoso xmlns:akn="http://docs.oasis-open.org/legaldocml/ns/akn/3.0"><akn:act><akn:meta><akn:identification source="#cosilico"><akn:FRBRWork prescriptive="true" authoritative="true"><akn:FRBRuri value="/akn/us/usc/42/290c" /><akn:FRBRdate date="2025-12-31" name="retrieval" /><akn:FRBRauthor href="#us-congress" /><akn:FRBRcountry value="us" /></akn:FRBRWork><akn:FRBRExpression><akn:FRBRuri value="/akn/us/usc/42/290c/eng@2025" /><akn:FRBRdate date="2025-12-31" /><akn:FRBRauthor href="#cosilico" /><akn:FRBRlanguage language="en" /></akn:FRBRExpression><akn:FRBRManifestation><akn:FRBRuri value="/akn/us/usc/42/290c/eng@2025/main.xml" /><akn:FRBRdate date="2025-12-31" /><akn:FRBRauthor href="#cosilico" /></akn:FRBRManifestation></akn:identification></akn:meta><akn:body><akn:section eId="sec_290c"><akn:num>290c</akn:num><akn:heading>Advanced Research Projects Agency–Health</akn:heading><akn:content><akn:p>§ 290c. Advanced Research Projects Agency–Health(a) Establishment(1) In generalThere is established within the National Institutes of Health the Advanced Research Projects Agency–Health (referred to in this section as “ARPA–H”). Not later than 180 days after December 29, 2022, the Secretary shall transfer all functions, personnel, missions, activities, authorities, and funds of the Advanced Research Projects Agency for Health as in existence on December 29, 2022, to ARPA–H established by the preceding sentence.


(2) Organization(A) In generalThere shall be within ARPA–H—(i) an Office of the Director;

(ii) not more than 8 program offices; and

(iii) such special project offices as the Director may establish.


(B) RequirementNot fewer than two-thirds of the program offices of ARPA–H shall be exclusively dedicated to supporting research and development activities, consistent with the goals and functions described in subsection (b).


(C) NotificationThe Director shall submit a notification to the Committee on Health, Education, Labor, and Pensions and the Committee on Appropriations of the Senate and the Committee on Energy and Commerce and the Committee on Appropriations of the House of Representatives if the Director determines that additional program offices are required to carry out this section.



(3) Exemption from certain policies of NIH(A) In generalExcept as otherwise provided for in this section, and subject to subparagraph (B), in establishing ARPA–H pursuant to paragraph (1), the Secretary may exempt ARPA–H from policies and requirements of the National Institutes of Health that are in effect on the day before December 29, 2022, as necessary and appropriate to ensure ARPA–H can most effectively achieve the goals described in subsection (b)(1).


(B) NoticeNot later than 90 days after December 29, 2022, the Secretary shall publish a notice in the Federal Register describing the specific policies and requirements of the National Institutes of Health from </akn:p></akn:content><akn:subsection eId="subsec_290c_a"><akn:num>(a)</akn:num><akn:heading>Establishment</akn:heading><akn:content><akn:p>(a) Establishment</akn:p></akn:content></akn:subsection><akn:subsection eId="subsec_290c_b"><akn:num>(b)</akn:num><akn:heading>Goals and functions</akn:heading><akn:content><akn:p>(b) Goals and functions</akn:p></akn:content></akn:subsection><akn:subsection eId="subsec_290c_c"><akn:num>(c)</akn:num><akn:heading>Director</akn:heading><akn:content><akn:p>(c) Director</akn:p></akn:content></akn:subsection><akn:subsection eId="subsec_290c_d"><akn:num>(d)</akn:num><akn:heading>Application of certain flexibilities</akn:heading><akn:content><akn:p>(d) Application of certain flexibilities The flexibilities provided to the National Institutes of Health under section 241(g) of this title shall apply to ARPA–H with respect to the functions described in subsection (b)(2).</akn:p></akn:content></akn:subsection><akn:subsection eId="subsec_290c_e"><akn:num>(e)</akn:num><akn:heading>Protection of information</akn:heading><akn:content><akn:p>(e) Protection of information</akn:p></akn:content></akn:subsection><akn:subsection eId="subsec_290c_f"><akn:num>(f)</akn:num><akn:heading>Cooperation with the Food and Drug Administration</akn:heading><akn:content><akn:p>(f) Cooperation with the Food and Drug Administration</akn:p></akn:content></akn:subsection><akn:subsection eId="subsec_290c_g"><akn:num>(g)</akn:num><akn:heading>Awards</akn:heading><akn:content><akn:p>(g) Awards</akn:p></akn:content></akn:subsection><akn:subsection eId="subsec_290c_h"><akn:num>(h)</akn:num><akn:heading>Facilities authority</akn:heading><akn:content><akn:p>(h) Facilities authority</akn:p></akn:content></akn:subsection><akn:subsection eId="subsec_290c_i"><akn:num>(i)</akn:num><akn:heading>Personnel</akn:heading><akn:content><akn:p>(i) Personnel</akn:p></akn:content></akn:subsection><akn:subsection eId="subsec_290c_j"><akn:num>(j)</akn:num><akn:heading>Program managers</akn:heading><akn:content><akn:p>(j) Program managers</akn:p></akn:content></akn:subsection></akn:section></akn:body></akn:act></akn:akomaNtoso>